Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:853 (8 April), doi:10.1136/bmj.332.7545.853
EDITORHunter and Felson deliver a consistent and seemingly thorough clinical review about managing knee osteoarthritis for primary care doctors.1 We commend them for promoting the role of non-pharmacological interventions and for highlighting the problem of inadequate funding because of "lucrative opportunities for drug development." However, one striking omission in their review was an appraisal of physical treatments, which are widely used in primary care. A cursory search of the literature identified at least 26 randomised placebo controlled trials and six systematic reviews of physical interventions for knee osteoarthritis in Medline indexed journals and the Cochrane Library.
One of the few examples where the efficacy of physical treatments was tested against drugs is a good quality independently funded trial, in which electroacupuncture showed better pain relief than non-steroidal anti-inflammatory drugs (diclofenac).2 A Cochrane review of transcutaneous electrical nerve stimulation (TENS) calculated the effect size for TENS v sham TENS as 0.38, even when inclusion criteria were not restricted to optimal doses.3
Attempts are being made to establish optimal doses for TENS, acupuncture, and low level laser treatment. Recent research in animals has established anti-inflammatory dose intervals for low level laser treatment, and this has been confirmed in situ with humans.4 A meta-analysis of such laser treatment in knee osteoarthritis when inclusion was limited to trials with optimal doses showed an effect size of 0.71.5 Optimal acupuncture, TENS, and low level laser treatment also seem to give persisting pain relief in knee osteoarthritis for some weeks after the end of treatment.
Jan M Bjordal, postdoctoral research fellow
Department of Public Health and Primary Health Care, University of Bergen, 5018 Bergen, Norway Jan.Bjordal{at}hib.no
Rodrigo Alvaro Brandao Lopes-Martins, assistant professor
Institute of Biomedicine, Pharmacology Department, University of Sao Paulo, Sao Paulo, Brazil
Bård Bogen, physiotherapist
Bergen Deaconal Hospital, Ulriksdal 10, 5009 Bergen
Mark Johnson, professor of pain and analgesia
Faculty of Health, Leeds Metropolitan University, Leeds LS1 3HE